Filing Details
- Accession Number:
- 0001161697-23-000623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-14 17:00:09
- Reporting Period:
- 2023-12-12
- Accepted Time:
- 2023-12-14 17:00:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1292636 | S David Tierney | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-12-12 | 50,000 | $1.13 | 383,541 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2023-12-12 | 50,000 | $13.33 | 333,541 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Acquisiton | 2023-12-12 | 50,000 | $0.00 | 50,000 | $1.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 244,264 | 2024-01-03 | No | 4 | M | Direct |
Footnotes
- Shares were sold on the open market for personal reasons, and to fund the exercise price for stock options expiring on January 3, 2024, and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.30 to $13.36 per share.
- Options vested in three annual tranches beginning on January 3, 2018.
Billionaire Hedge Funds
